Mismatch repair deficiency in metastatic prostate cancer: Response to PD-1 blockade and standard therapies. Graham LS, Montgomery B, Cheng HH, Yu EY, et al. PLoS One 2020;15:e0233260.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Graham LS, Montgomery B, Cheng HH, Yu EY, et al. Mismatch repair deficiency in metastatic prostate cancer: Response to PD-1 blockade and standard therapies. PLoS One 2020;15:e0233260.
PMID: 32453797